Carbapenem-resistant Klebsiella pneumoniae in ICU-admitted COVID-19 patients: Keep an eye on the ball
Giorgia Montrucchio, Silvia Corcione, Gabriele Sales, Antonio Curtoni, Francesco Giuseppe De Rosa, Luca Brazzi
Abstract
Here we report on seven intensive care unit (ICU) patients with coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome (ARDS) who developed positive rectal swabs and invasive infections due to carbapenemase-producing Klebsiella pneumoniae (CP-Kp). Notwithstanding the infection prevention measures introduced during the COVID-19 pandemic and changes in the hospitalised population, attention to CP-Kp infections must remain high, especially in the critically ill setting.
Topics & Concepts
Klebsiella pneumoniaeMedicineIntensive care unitARDSPandemicCoronavirus disease 2019 (COVID-19)Acute respiratory distressIntensive care medicinePopulationInfectious disease (medical specialty)Internal medicineDiseaseLungBiologyGeneBiochemistryEscherichia coliEnvironmental healthAntibiotic Use and ResistanceCOVID-19 Clinical Research StudiesNosocomial Infections in ICU